Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors

NCT00094159 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sunesis Pharmaceuticals